← Leaderboards
Paul Bernard Romesser
Sloan-Kettering Inst Can Research
$1,968,392
Attributed
$1,968,392
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $948.2K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,968,392 · 2
By mechanism
K08$1,237,994 · 1
R37$730,398 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Michelle S Bradbury$7,087,200
- Ulrich Wiesner$4,616,977
- Michael H. Overholtzer$11,387,854
- Jedd D. Wolchok$10,212,450
- Tomas Kirchhoff$7,026,619
Others in their field
Other Emerging Leaders on “Programs”
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$348,328,584
- Lynn Briscoe · Leidos Biomedical Research, Inc.$312,382,073
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
ProgramsSamplingMediatingPositioning AttributeRadiation TherapyResponseImmuneImmunoregulationMouse ModelPathway InteractionsAnti-Pd1 TherapyChemoradiationRadiation ToleranceRectal CancerDna DamageEffector CellCellsCancer PatientCell Cycle ArrestModalityNeoplastic CellOrganoidsCancer ModelSenescence
Grant awards (6)
Leveraging Radiation-Induced Senescence and PTPN2 Inhibition to Enhance Immune-Mediated Tumor Control in Rectal Cancer$730,398
R37 · FY2025 · CA · contact PI
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.$217,814
K08 · FY2025 · CA · contact PI
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.$255,045
K08 · FY2024 · CA · contact PI
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.$255,045
K08 · FY2023 · CA · contact PI
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.$255,045
K08 · FY2022 · CA · contact PI
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.$255,045
K08 · FY2021 · CA · contact PI